237 related articles for article (PubMed ID: 1519227)
21. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
22. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF
Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053
[TBL] [Abstract][Full Text] [Related]
23. Protracted treatment with phorbol ester modulates J-7 human hepatoma-cell-induced aggregation and coagulation of human platelet-rich plasma.
Ko FN; Yu SM; Teng CM
Int J Cancer; 1994 Dec; 59(5):706-11. PubMed ID: 7960244
[TBL] [Abstract][Full Text] [Related]
24. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM
J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698
[TBL] [Abstract][Full Text] [Related]
25. In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice.
Sheu JR; Chao SH; Yen MH; Huang TF
Thromb Haemost; 1994 Oct; 72(4):617-21. PubMed ID: 7878641
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
27. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
Rahman S; Lu X; Kakkar VV; Authi KS
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
[TBL] [Abstract][Full Text] [Related]
28. Biochemical characterization of a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venom.
Kawasaki T; Sakai Y; Taniuchi Y; Sato K; Maruyama K; Shimizu M; Kaku S; Yano S; Inagaki O; Tomioka K; Yanagisawa I; Takenaka T
Biochimie; 1996; 78(4):245-52. PubMed ID: 8874799
[TBL] [Abstract][Full Text] [Related]
29. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity.
Knapp A; Degenhardt T; Dodt J
J Biol Chem; 1992 Dec; 267(34):24230-4. PubMed ID: 1447173
[TBL] [Abstract][Full Text] [Related]
30. Triflavin, an antiplatelet peptide, inhibits tumor cell-extracellular matrix adhesion through an arginine-glycine-aspartic acid-dependent mechanism.
Sheu JR; Lin CH; Huang TF
J Lab Clin Med; 1994 Feb; 123(2):256-63. PubMed ID: 8301202
[TBL] [Abstract][Full Text] [Related]
31. Isolation and amino acid sequence of flavostatin, a novel disintegrin from the venom of Trimeresurus flavoviridis.
Maruyama K; Kawasaki T; Sakai Y; Taniuchi Y; Shimizu M; Kawashima H; Takenaka T
Peptides; 1997; 18(1):73-8. PubMed ID: 9114455
[TBL] [Abstract][Full Text] [Related]
32. A new short chain RGD-containing disintegrin, accutin, inhibits the common pathway of human platelet aggregation.
Yeh CH; Peng HC; Yih JB; Huang TF
Biochim Biophys Acta; 1998 Nov; 1425(3):493-504. PubMed ID: 9838213
[TBL] [Abstract][Full Text] [Related]
33. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
Foster MR; Hornby EJ; Brown S; Kitchin J; Hann M; Ward P
Thromb Res; 1993 Nov; 72(3):231-45. PubMed ID: 8303662
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide.
Ugen KE; Mahalingam M; Klein PA; Kao KJ
J Natl Cancer Inst; 1988 Nov; 80(18):1461-6. PubMed ID: 3184195
[TBL] [Abstract][Full Text] [Related]
35. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
[TBL] [Abstract][Full Text] [Related]
36. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
37. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia.
Sheu JR; Hung WC; Wu CH; Ma MC; Kan YC; Lin CH; Lin MS; Luk HN; Yen MH
Circulation; 1999 Jun; 99(23):3056-62. PubMed ID: 10368125
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
Foster MR; Hornby EJ; Brown S; Hann M; Kitchin J; Pike N; Ward P
Thromb Res; 1994 Aug; 75(3):269-84. PubMed ID: 7992238
[TBL] [Abstract][Full Text] [Related]
40. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis.
Liu CZ; Peng HC; Huang TF
Toxicon; 1995 Oct; 33(10):1289-98. PubMed ID: 8599180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
